Page 5 - Darrell Crate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The choices are easy with these great stocks.

Greetings and welcome to Easterly Government Properties' Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. It is now -- I would now like to turn the conference over to your host; Lindsay Winterhalter, Vice President Investor Relations. Lindsay Winterhalter -- Vice President-Investor Relations And Operations Good morning. Before the call begins, please note the use of forward-looking statements by the Company on this conference call. Statements made on this call may include statements which are not historical facts and are considered forward-looking. The Company intends t...

Attractive yields and strong businesses make these dividend stocks great picks right now.

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights In a world of dizzying changes, it's nice to have at least a few constants. These are things that don't change -- at least not in a bad way. You can count on them year in and year out. This is especially important for income-seeking investors. You don't want to have to whipsa...

AbbVie (NYSE:ABBV). The big drug stock offers income, value, and growth.  AbbVie's dividend yield currently stands at close to 4.5%. The company has increased its dividend by a whopping 225% since its spin-off from Abbott in 2013. It's also a Dividend Aristocrat with 49 consecutive annual dividend increases. Many investors would also consider AbbVie a bargain. Its shares trade at a little over nine times expected earnings. That's well below the forward earnings multiple of 13.5 for the pharmaceutical companies in the S&P 500.  AbbVie should even deliver solid long-term growth. Granted, th...